BETAHISTINE GPPL betahistine dihydrochloride 16 mg tablets blister packs

Country: Australia

Bahasa: Inggeris

Sumber: Department of Health (Therapeutic Goods Administration)

Beli sekarang

Laporan Penilaian Awam Laporan Penilaian Awam (PAR)
26-11-2017

Bahan aktif:

betahistine dihydrochloride, Quantity: 16 mg

Boleh didapati daripada:

Arrotex Pharmaceuticals Pty Ltd

INN (Nama Antarabangsa):

betahistine dihydrochloride

Borang farmaseutikal:

Tablet, uncoated

Komposisi:

Excipient Ingredients: mannitol; microcrystalline cellulose; purified talc; citric acid; colloidal anhydrous silica

Laluan pentadbiran:

Oral

Unit dalam pakej:

60 tablets, 10 tablets, 30 tablets, 100 tablets, 25 tablets

Jenis preskripsi:

(S4) Prescription Only Medicine

Tanda-tanda terapeutik:

Meniere's Syndrome as defined by the following core symptoms: vertigo (with nausea/vomiting), hearing loss (hardness of hearing) and tinnitus.

Ringkasan produk:

Visual Identification: Uncoated, round, biconvex, white to light creamy tablets, with a groove on one surface.; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Status kebenaran:

Registered

Tarikh kebenaran:

2014-08-14